Quanterix
Quanterix's Overview
Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s ultra-sensitive detection solution, Simoa®, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine critical biomarkers in numerous therapeutic areas, including neurology, oncology, cardiology, inflammation, and infectious disease. Quanterix’s technology is designed to enable much earlier disease detection, better prognoses, and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas.
Where is Quanterix's Headquarters?
HQ Function
Serves as the primary hub for corporate operations, research and development, manufacturing of Simoa® instruments and consumables, and customer support.
Notable Features:
State-of-the-art laboratory facilities for biomarker research and assay development, advanced manufacturing lines, and collaborative office spaces designed to foster innovation.
Work Culture:
The work culture at Quanterix emphasizes innovation, collaboration, scientific rigor, and a strong sense of mission towards improving human health. Employees often describe it as fast-paced and dynamic, with opportunities for growth and impact.
HQ Significance:
The Billerica headquarters is central to Quanterix's ability to innovate, produce, and distribute its cutting-edge Simoa technology globally, positioning it within a key biotech ecosystem.
Values Reflected in HQ: The headquarters reflects Quanterix's commitment to scientific excellence, technological innovation, precision, and its mission-driven approach to advancing healthcare.
Location:
Quanterix supports its global customer base through direct operations in North America (headquartered in Billerica, MA) and Europe (Quanterix GmbH in Freiburg, Germany). Additionally, they have an extensive network of distributors and partners to serve customers in Asia-Pacific, Latin America, and other regions worldwide. This global infrastructure ensures sales, service, and support for its Simoa platform across key research and clinical markets.
Street Address:
900 Middlesex Turnpike, Building 1
City:
Billerica
State/Province:
MA
Country:
USA
Quanterix's Global Presence
Freiburg, Germany
Address: Engesserstrasse 4a, 79108 Freiburg im Breisgau, Germany
To expand Quanterix's footprint in the European market, provide localized customer service and application support, and facilitate collaborations with European research institutions and pharmaceutical companies.
Buying Intent Signals for Quanterix
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Quanterix
As of April 2025, Quanterix' leadership includes:
Investors of Quanterix
Quanterix has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Over the past year, Quanterix has maintained relative stability in its core C-suite leadership. Any significant changes are typically announced via press releases and financial disclosures.
Departures
New Appointments:
Technology (Tech Stack) used by Quanterix
Discover the tools Quanterix uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Quanterix Email Formats and Examples
Quanterix typically uses a standard email format, most commonly combining the first initial and last name of the employee. This is a common convention in many corporations.
flast@quanterix.com (e.g., jdoe@quanterix.com)
Format
mtoloue@quanterix.com (Illustrative for Masoud Toloue, CEO)
Example
90%
Success rate
News and media
Business Wire • May 7, 2024
Quanterix Reports First Quarter 2024 Financial Results
Quanterix Corporation announced its financial results for the first quarter ended March 31, 2024. The company highlighted progress in its strategic initiatives, including instrument placements and consumable sales, and discussed its outlook for the remainder of the year. Key figures included total revenue of $29.7 million....more
Business Wire • April 2, 2024
Quanterix NfL Test Receives FDA Breakthrough Device Designation for Use as an Aid in the Diagnosis of Multiple Sclerosis
Quanterix announced that its Simoa® neurofilament light chain (NfL) plasma test has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) as a prognostic aid in assessing the risk of disease activity in adults diagnosed with relapsing-remitting multiple sclerosis (MS)....more
Business Wire • February 27, 2024
Quanterix Reports Fourth Quarter and Full Year 2023 Financial Results
Quanterix reported its financial results for the fourth quarter and full year ended December 31, 2023. The company emphasized growth in its core business areas and advancements in its product pipeline, including achieving total revenue of $30.4 million for Q4 2023 and $121.1 million for the full year 2023....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Quanterix, are just a search away.